The Global Varicella Vaccine Market is estimated to account for over US$ 3,256.1 million by 2019. The market is anticipated to grow at a CAGR of 12.3% from 2020 to 2030.
The growth of the global varicella vaccine market can be attributed to several factors, which has led to its wide-scale adoption. Better access to vaccines worldwide and growth of pediatric & adult population are anticipated to further contribute to the substantial growth of market between 2019 and 2030. However, complex government rules & regulations monitoring R&D and clinical studies of vaccine are likely to restrain the market to a certain extent.
Top Players:
Some of the prominent players in the varicella vaccine market include Merck & Co., Inc., GlaxoSmithKline plc., Shanghai Biological Products Research Institute Co., Ltd., BIKEN, Green Cross, Changchun BCHT Biotechnology Co., Novo and SK bioscience among others.
Get Sample Copy with TOC @ https://www.marketindustryreports.com/pdf/247
Scope of Report
To obtain better insights regarding the market scenario, prominent players are increasingly focusing on collaborative initiatives with several institutes, research centers, and companies. For instance, In Feb 2018, VARIVAX, a live attenuated varicella-zoster (VZV) vaccine from Merck & Co., Inc, was awarded pre-qualification status by the World Health Organization (WHO). WHO pre-qualification allowed VARIVAX to expand access and provides a greater opportunity to help protect more people from varicella.
Regional Analysis:
Asia Pacific is the fastest-growing market for varicella vaccine and is anticipated to contribute significantly to the global market share. The growth in this region can be attributed to the improving healthcare infrastructure and rising awareness related to importance of immunization. Countries in the APAC, such as India, China, and Japan, are anticipated to provide significant growth opportunities for the global varicella vaccine market owing to increasing immunization programs.
Ask for Discount @ https://www.marketindustryreports.com/discount/247
Segmentation Based On:
By Product Type
1.Monovalent Varicella Vaccine
2.Combination Varicella Vaccine
By Patient Type
1.Pediatric Patients
2.Adult Patients
Table of Contents
- INTRODUCTION
- Market Definition
- Market Ecosystem
- Market Classification
- Geographic Scope
- Years Considered for the Study
- Historical Years – 2016 & 2017
- Base Year – 2018
- Forecasted Years – 2019 to 2030
- Currency Used for the Study
- Report Beneficiary List
- RESEARCH METHODOLOGY
- Research Framework
- Data Collection Technique
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Methodology
- Bottoms Up Approach
- Top Down Approach
- Data Validation and Triangulation
- Market Forecasting Model
- Limitations of the Study
- Assumptions of the Study
- ABSTRACT OF THE STUDY
- MARKET DYNAMICS ASSESMENT
- Overview
- Drivers
- Barriers/Challenges
- Opportunities
- UNIQUE SELLING PROPOSITIONS (USPs)
- Technological Advancement
- Application Horizon Assessment
- Initiatives Assessment: Government & Private Bodies
Have any query? Inquiry here for Customization about report at:
https://www.marketindustryreports.com/inquiry/247
About Market Industry Reports:
Market Industry Reports is a global leader in market measurement & advisory services, Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.
Contact Us:
Phone: + 91 8956767535
Email: sales@marketindustryreports.com
Website: www.marketindustryreports.com
